Starting in October 2026, all newborns in England will be routinely screened for spinal muscular atrophy (SMA), a rare but serious muscle-wasting disease. This screening program is set to begin three months earlier than initially planned, following a government commitment to accelerate its rollout.
SMA is a genetic condition that can severely affect infants, impacting their ability to sit, crawl, or walk. In the most extreme cases, it impairs breathing and swallowing. However, early detection through newborn screening enables timely access to treatments that can greatly improve the lives of affected children.
The screening test is simple and non-invasive, involving a heel prick to collect a small blood sample soon after birth. NHS laboratories across England will implement this testing as part of the national newborn blood spot screening program.
READ MORE: Man Sentenced After Dragging Woman by Hair Outside Birmingham Pub
READ MORE: New Pay Transparency Rule Proposed for All Workers in England
Giles Lomax, Chief Executive of Spinal Muscular Atrophy UK, called the new screening an “incredibly important step forward,” highlighting the thousands of babies who will benefit from early diagnosis and life-changing therapies.
Muscular Dystrophy UK’s Chief Executive, Andy Fletcher, described the introduction of universal SMA screening as a “landmark moment” for families affected by the disease and praised the years of work that led to this milestone.
The campaign for universal SMA screening also garnered support from Little Mix singer Jesy Nelson, whose twin daughters were diagnosed with the condition. Nelson expressed her gratitude and hope, saying, “Today is a day of hope. This is a victory for every family affected by SMA and marks the beginning of a brighter future for new SMA families.”
The Department of Health and Social Care will be seeking investment to fully support and fund this important initiative, ensuring all newborn screening laboratories in England offer this life-saving test by the end of 2027.